Vaginal discharge: Difference between revisions
Agnesrinky (talk | contribs) No edit summary |
Agnesrinky (talk | contribs) |
||
Line 96: | Line 96: | ||
==Treatment== | ==Treatment== | ||
''' | '<span style="font-size:85%">'''Abbreviations:''' '''QHS''' : Every bedtime , '''BID''': 2 times daily, '''TID''': Three times a day, '''QID''': Four times a day, '''IM''' :Intramuscular | ||
<br /> | |||
{| style="border: 2px solid #4479BA; align=" left" | |||
! style="width: Organism; background: #4479BA;" |{{fontcolor|#FFF|[[Organisms]]}} | |||
! style="width: Recommended Drugs; background: #4479BA;" |{{fontcolor|#FFF|Recommended [[Drugs]]}} | |||
! style="width: Alternative drugs; background: #4479BA;" |{{fontcolor|#FFF|Alternative [[drugs]]}} | |||
|- | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Candidiasis]] | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | |||
'''Over-the-Counter Intravaginal Agents'''<ref name="urlVulvovaginal Candidiasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/candidiasis.htm |title=Vulvovaginal Candidiasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
*[[Clotrimazole]] 1% cream 5 g intravaginally daily for 7–14 days | |||
OR | |||
*[[Clotrimazole]] 2% cream 5 g intravaginally daily for 3 days | |||
OR | |||
*[[Miconazole]] 2% cream 5 g intravaginally daily for 7 days | |||
OR | |||
*[[Miconazole]] 4% cream 5 g intravaginally daily for 3 days | |||
OR | |||
*[[Miconazole]] 100 mg vaginal suppository, one [[suppository]] daily for 7 days | |||
OR | |||
*[[Miconazole]] 200 mg vaginal suppository, one [[suppository]] for 3 days | |||
OR | |||
*[[Miconazole]] 1,200 mg vaginal [[suppository]], one [[suppository]] for 1 day | |||
OR | |||
*[[Tioconazole]] 6.5% [[ointment]] 5 g intravaginally in a single application | |||
'''Prescription Intravaginal Agents:''' | |||
*[[Butoconazole]] 2% cream (single dose bioadhesive product), 5 g intravaginally in a single application | |||
OR | |||
*[[Terconazole]] 0.4% cream 5 g intravaginally daily for 7 days | |||
OR | |||
*[[Terconazole]] 0.8% cream 5 g intravaginally daily for 3 days | |||
OR | |||
*[[Terconazole]] 80 mg [[Vagina|vaginal]] [[suppository]], one [[suppository]] daily for 3 days | |||
'''Oral Agent:''' | |||
*[[Fluconazole]] 150 mg orally in a single dose | |||
<br /> | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | |||
[[Nystatin]] 1,00,000 unit tab [[Vagina|vaginally]] QHS for 2 weeks<ref name="pmid21263805">{{cite journal |vauthors=Watson WJ, Demarchi G |title=Vaginal discharge: an approach to diagnosis and management |journal=Can Fam Physician |volume=33 |issue= |pages=1847–52 |date=August 1987 |pmid=21263805 |pmc=2218224 |doi= |url= |issn=}}</ref> | |||
|- | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Trichomoniasis]] | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | |||
*[[Metronidazole]] 2 g orally in a single dose<ref name="urlTrichomoniasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/trichomoniasis.htm |title=Trichomoniasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
OR | |||
*[[Tinidazole]] 2 g orally in a single dose<ref name="urlTrichomoniasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/trichomoniasis.htm |title=Trichomoniasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
<br /> | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | |||
*[[Metronidazole]] 500 mg orally twice a day for 7 days<ref name="urlTrichomoniasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/trichomoniasis.htm |title=Trichomoniasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
OR | |||
*[[Clotrimazole]] 2 X 100 mg [[Vagina|vaginal]] tabs QHS for 7days<ref name="urlTrichomoniasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/trichomoniasis.htm |title=Trichomoniasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
* | |||
|- | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Bacterial Vaginosis]] | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | |||
*[[Metronidazole]] 500 mg orally twice a day for 7 days<ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
OR | |||
*[[Metronidazole]] gel 0.75%, one full applicator (5 g) intravaginally, once a day for 5 days<ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
OR | |||
*[[Clindamycin]] cream 2%, one full applicator (5 g) intravaginally at bedtime for 7 days<ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | |||
*[[Tinidazole]] 2 g orally once daily for 2 days <ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
OR | |||
*[[Tinidazole]] 1 g orally once daily for 5 days <ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
OR | |||
*[[Clindamycin]] 300 mg orally twice daily for 7 days <ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
OR | |||
*[[Clindamycin]] ovules 100 mg intravaginally once at bedtime for 3 days<ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
|- | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Neisseria gonorrheae|Neisseria gonorrhoea]] | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | |||
[[Amoxicillin]] orally 3 gm single [[dose]] <br> or <br>[[Ampicillin]] [[Oral|orally]] 3.5 gm single dose <br> or <br>[[Procaine]] PCN G 4.8 million IM single [[dose]] <ref name="pmid21263805">{{cite journal |vauthors=Watson WJ, Demarchi G |title=Vaginal discharge: an approach to diagnosis and management |journal=Can Fam Physician |volume=33 |issue= |pages=1847–52 |date=August 1987 |pmid=21263805 |pmc=2218224 |doi= |url= |issn=}}</ref> | |||
<br> '''PLUS''' | |||
<br> [[Probenecid]] 1 gm orally single [[dose]] <ref name="pmid21263805">{{cite journal |vauthors=Watson WJ, Demarchi G |title=Vaginal discharge: an approach to diagnosis and management |journal=Can Fam Physician |volume=33 |issue= |pages=1847–52 |date=August 1987 |pmid=21263805 |pmc=2218224 |doi= |url= |issn=}}</ref> | |||
<br> '''AND''' | |||
<br> [[Tetracycline]] 500 mg orally QID for 7 days <br> or<br> [[Doxycycline]] 100 mg [[Oral|orally]] BID for 7 days <br> or<br> [[Ceftriaxone]] 250 mg IM single dose<ref name="pmid21263805">{{cite journal |vauthors=Watson WJ, Demarchi G |title=Vaginal discharge: an approach to diagnosis and management |journal=Can Fam Physician |volume=33 |issue= |pages=1847–52 |date=August 1987 |pmid=21263805 |pmc=2218224 |doi= |url= |issn=}}</ref> | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | |||
[[Erythromycin]] 500 mg orally QID for 7 days<ref name="pmid21263805">{{cite journal |vauthors=Watson WJ, Demarchi G |title=Vaginal discharge: an approach to diagnosis and management |journal=Can Fam Physician |volume=33 |issue= |pages=1847–52 |date=August 1987 |pmid=21263805 |pmc=2218224 |doi= |url= |issn=}}</ref> <br> or<br>[[Tetracycline]] 500 mg orally QID for 7 days<ref name="pmid21263805">{{cite journal |vauthors=Watson WJ, Demarchi G |title=Vaginal discharge: an approach to diagnosis and management |journal=Can Fam Physician |volume=33 |issue= |pages=1847–52 |date=August 1987 |pmid=21263805 |pmc=2218224 |doi= |url= |issn=}}</ref> <br> or<br> [[Doxycycline]] 100 mg orally BID for 7 days<ref name="pmid21263805">{{cite journal |vauthors=Watson WJ, Demarchi G |title=Vaginal discharge: an approach to diagnosis and management |journal=Can Fam Physician |volume=33 |issue= |pages=1847–52 |date=August 1987 |pmid=21263805 |pmc=2218224 |doi= |url= |issn=}}</ref> <br> or <br>[[Spectinomycin]] 2 gm IM single [[dose]] | |||
|- | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Chlamydia trachomatis]] | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | |||
[[Tetracycline]] 500 mg orally QID for 7 days<ref name="pmid21263805">{{cite journal |vauthors=Watson WJ, Demarchi G |title=Vaginal discharge: an approach to diagnosis and management |journal=Can Fam Physician |volume=33 |issue= |pages=1847–52 |date=August 1987 |pmid=21263805 |pmc=2218224 |doi= |url= |issn=}}</ref> <br>or<br> [[Doxycycline]] 100 mg [[Oral|orally]] BID for 7 days<ref name="pmid21263805">{{cite journal |vauthors=Watson WJ, Demarchi G |title=Vaginal discharge: an approach to diagnosis and management |journal=Can Fam Physician |volume=33 |issue= |pages=1847–52 |date=August 1987 |pmid=21263805 |pmc=2218224 |doi= |url= |issn=}}</ref> | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | |||
[[Erythromycin]] base 500 mg orally QID for 7 days<ref name="pmid21263805">{{cite journal |vauthors=Watson WJ, Demarchi G |title=Vaginal discharge: an approach to diagnosis and management |journal=Can Fam Physician |volume=33 |issue= |pages=1847–52 |date=August 1987 |pmid=21263805 |pmc=2218224 |doi= |url= |issn=}}</ref> <br> or<br> [[Erythromycin]] ethylsuccinate 800 mg orally QID for 7 days<ref name="pmid21263805">{{cite journal |vauthors=Watson WJ, Demarchi G |title=Vaginal discharge: an approach to diagnosis and management |journal=Can Fam Physician |volume=33 |issue= |pages=1847–52 |date=August 1987 |pmid=21263805 |pmc=2218224 |doi= |url= |issn=}}</ref> <br> or<br> [[Sulfamethoxazole]] 1gm [[Oral|orally]] BID for 10 days | |||
<br /> | |||
|- | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Herpes simplex|Herpes Simplex]] | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | |||
[[Acyclovir]]<ref name="pmid21263805">{{cite journal |vauthors=Watson WJ, Demarchi G |title=Vaginal discharge: an approach to diagnosis and management |journal=Can Fam Physician |volume=33 |issue= |pages=1847–52 |date=August 1987 |pmid=21263805 |pmc=2218224 |doi= |url= |issn=}}</ref> | |||
<br /> | |||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | |||
|- | |||
|} | |||
Patient should be referred to a [[gynecologist]] if following are present. <ref name="SimLogan2020">{{cite journal|last1=Sim|first1=M|last2=Logan|first2=S|last3=Goh|first3=LH|title=Vaginal discharge: evaluation and management in primary care|journal=Singapore Medical Journal|year=2020|pages=297–301|issn=00375675|doi=10.11622/smedj.2020088}}</ref> | |||
*Retained [[foreign bodies]]. | |||
*Recent instrumentation or [[surgery]] of the [[Genital area|genital tract]] such as [[hysterosalpingography]], [[Dilation and curettage (patient information)|dilation and curettage]], [[hysteroscopy]], termination of [[pregnancy]]/evacuation of retained products of [[conception]], [[laparoscopy]] and major [[Gynaecology|gynaecological]] [[surgical procedure]]. | |||
*Suspected [[tumor]] of the [[Genital area|genital tract]]. | |||
*[[Cervical]] ectopy or [[Polyp|polyps]]. | |||
*Recurrent [[Vulvovaginal Candidosis|vulvovaginal]] [[Candidiasis|candida infections]]. | |||
*[[Pregnancy|Pregnant]] woman with abnormal [[vaginal discharge]] | |||
*Symptoms of upper [[Genital|genital tract]] [[Infection|infections]] as [[fever]], [[lower abdominal pain]] | |||
'''Treatment in pregnancy:''' | |||
*[[Vulvovaginal Candidosis|Vulvovaginal]] [[Candidiasis]]: It frequently occurs during [[pregnancy]]. Only topical [[azole]] therapies for 7 days are recommended for use among pregnant women.<ref name="urlVulvovaginal Candidiasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/candidiasis.htm |title=Vulvovaginal Candidiasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
*[[Trichomoniasis]]: [[Metronidazole]] 2 g orally single dose is recommended. Symptomatic [[Pregnancy|pregnant]] women, regardless of [[pregnancy]] stage, should be tested and considered for treatment.<ref name="urlTrichomoniasis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/trichomoniasis.htm |title=Trichomoniasis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
*[[Bacterial vaginosis]]: Treatment is recommended for all symptomatic [[Pregnancy|pregnant]] women. [[Metronidazole]] 250-mg regimen is effective. But, [[Metronidazole]] 500 mg twice daily can be used.<ref name="urlBacterial Vaginosis - 2015 STD Treatment Guidelines">{{cite web |url=https://www.cdc.gov/std/tg2015/bv.htm |title=Bacterial Vaginosis - 2015 STD Treatment Guidelines |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
==Acute pharmacotherapies== | ==Acute pharmacotherapies== |
Revision as of 08:35, 22 May 2021
For patient information, click here
WikiDoc Resources for Vaginal discharge |
Articles |
---|
Most recent articles on Vaginal discharge Most cited articles on Vaginal discharge |
Media |
Powerpoint slides on Vaginal discharge |
Evidence Based Medicine |
Cochrane Collaboration on Vaginal discharge |
Clinical Trials |
Ongoing Trials on Vaginal discharge at Clinical Trials.gov Trial results on Vaginal discharge Clinical Trials on Vaginal discharge at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Vaginal discharge NICE Guidance on Vaginal discharge
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Vaginal discharge Discussion groups on Vaginal discharge Patient Handouts on Vaginal discharge Directions to Hospitals Treating Vaginal discharge Risk calculators and risk factors for Vaginal discharge
|
Healthcare Provider Resources |
Causes & Risk Factors for Vaginal discharge |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shankar Kumar, M.B.B.S. [2] Samah ObaiahRinky Agnes Botleroo, M.B.B.S.
Synonyms and keywords: Discharge from the vagina
Overview
Vaginal discharge is a common patient complaint that is paired with anxiety regarding sexually transmitted diseases. If a STD is detected, a search for all other STDs should be done. Advise the infected patient to inform all sexual partners of their diagnosis.Also there is normal vaginal discharge depends on periodic hormonal change[1]
Causes
Common Causes
- Atrophic vaginitis or senile vaginitis, it as a result of estrogen deficiency lead to vaginal dryness, itching, irritation, discharge, and dyspareunia[2]
- Bacterial vaginosisis mostally happen during the reproductive age of women characterized by a shift in the vaginal flora from the dominant Lactobacillus to a polymicrobial flora[3]
- Cervical cancer[4]
- Chlamydia,sexually transmitted infections.
- Foreign body vaginitis
- Gonorrhea,sexually transmitted infections[4]
- Herpes[5]
- Trichomoniasis,a parasitic infection typically contracted and caused by having unprotected sex[6]
- Vaginal cancer
- Vaginal yeast infection
- Diabetes
- Drug side effect as antibiotic or steroid use as, Amoxicillin and Clavulanic Acid , Butoconazole Vaginal Cream , Clotrimazole , Combined oral contraceptive pill, Estradiol Topical , Estradiol Transdermal , Estrogen and Progestin (Oral Contraceptives) ,Estrogen Injection , Estrogen Vaginal , Etonogestrel and Ethinyl Estradiol Vaginal Ring , Glatiramer Injection ,Hormone replacement therapy (trans), Letrozole, Leuprolide , Medroxyprogesterone Injection , Metronidazole Topical ,Miconazole , Nafarelin , Natalizumab injection , Norelgestromin and ethinyl estradiol transdermal system , Ospemifene, Oxcarbazepine , Pramipexole, Progesterone, Tamoxifen , Terconazole Vaginal Cream, Vaginal Suppositories , Toremifene, Zoledronic Acid Injection
Classification
Normal vaginal discharge as in Neonatal, Pediatric, Puberty, Menstrual cycle[7], Pregnancy, and Menopause. -Abnormal vaginal discharge as
Laboratory findings
Initial tests include:
- CBC
- Urinalysis
- Urine culture
- Beta-hCG
- Gonorrhea culture
- Chlamydia culture
Other Diagnostic Studies
Type | pH | Discharge | Odor | Wet Mount |
Trich | >4.5 | yellow-green, copious | present | motile, flagellated |
BV | >4.5 | white-grey | fishy | clue cells |
Candida | <4.5 | white, curd-like | none | pseudo-hyphae |
GC | mucopurulent | varies | PMNs | |
A.V. | thin, gray, watery | none | few epithelial cells |
Treatment
'Abbreviations: QHS : Every bedtime , BID: 2 times daily, TID: Three times a day, QID: Four times a day, IM :Intramuscular
Organisms | Recommended Drugs | Alternative drugs |
---|---|---|
Candidiasis |
Over-the-Counter Intravaginal Agents[8]
OR
OR
OR
OR
OR
OR
OR
Prescription Intravaginal Agents:
OR
OR
OR
Oral Agent:
|
|
Trichomoniasis |
OR
|
OR
|
Bacterial Vaginosis |
OR
OR
|
OR
OR
OR
|
Neisseria gonorrhoea |
Amoxicillin orally 3 gm single dose
|
Erythromycin 500 mg orally QID for 7 days[9] |
Chlamydia trachomatis |
Tetracycline 500 mg orally QID for 7 days[9] |
Erythromycin base 500 mg orally QID for 7 days[9] |
Herpes Simplex |
|
Patient should be referred to a gynecologist if following are present. [12]
- Retained foreign bodies.
- Recent instrumentation or surgery of the genital tract such as hysterosalpingography, dilation and curettage, hysteroscopy, termination of pregnancy/evacuation of retained products of conception, laparoscopy and major gynaecological surgical procedure.
- Suspected tumor of the genital tract.
- Cervical ectopy or polyps.
- Recurrent vulvovaginal candida infections.
- Pregnant woman with abnormal vaginal discharge
- Symptoms of upper genital tract infections as fever, lower abdominal pain
Treatment in pregnancy:
- Vulvovaginal Candidiasis: It frequently occurs during pregnancy. Only topical azole therapies for 7 days are recommended for use among pregnant women.[8]
- Trichomoniasis: Metronidazole 2 g orally single dose is recommended. Symptomatic pregnant women, regardless of pregnancy stage, should be tested and considered for treatment.[10]
- Bacterial vaginosis: Treatment is recommended for all symptomatic pregnant women. Metronidazole 250-mg regimen is effective. But, Metronidazole 500 mg twice daily can be used.[11]
Acute pharmacotherapies
Bacterial Vaginosis
- Metronidazole single dose for 7 days
Candida and Chlamydia
Gonorrhea
- Oral ciprofloxacin or IM ceftriaxone
Trichomonas
- Metronidazole single dose for 7 days
- Intravaginal clotrimazole if pregnant or unable to use Metronidazole
References
- ↑ Spence D, Melville C (2007). "Vaginal discharge". BMJ. 335 (7630): 1147–51. doi:10.1136/bmj.39378.633287.80. PMC 2099568. PMID https://www.ncbi.nlm.nih.gov/pubmed/18048541 Check
|pmid=
value (help). - ↑ Hainer BL, Gibson MV (2011). "Vaginitis". Am Fam Physician. 83 (7): 807–15. PMID 21524046.
- ↑ Cettl L, Dvorak J, Felkel H, Feuereisl R (1979). "Results of simulation of non-homogeneous ventilatory mechanics for a patient-computer arrangement". Int J Biomed Comput. 10 (1): 67–74. doi:10.1016/0020-7101(79)90042-4. PMID http://www.ncbi.nlm.nih.gov/pmc/articles/pmc478688 Check
|pmid=
value (help). - ↑ 4.0 4.1 4.2 Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.1016/j.ogrm.2016.08.002 Check
|pmid=
value (help). - ↑ Wathne B, Holst E, Hovelius B, Mårdh PA (1994). "Vaginal discharge--comparison of clinical, laboratory and microbiological findings". Acta Obstet Gynecol Scand. 73 (10): 802–8. doi:10.3109/00016349409072509. PMID https://pubmed.ncbi.nlm.nih.gov/7817733 Check
|pmid=
value (help). - ↑ Spence D, Melville C (2007). "Vaginal discharge". BMJ. 335 (7630): 1147–51. doi:10.1136/bmj.39378.633287.80. PMC 2099568. PMID https://pubmed.ncbi.nlm.nih.gov/18048541 Check
|pmid=
value (help). - ↑ Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A; et al. (2000). "Endotext". PMID https://pubmed.ncbi.nlm.nih.gov/25905282 Check
|pmid=
value (help). - ↑ 8.0 8.1 "Vulvovaginal Candidiasis - 2015 STD Treatment Guidelines".
- ↑ 9.00 9.01 9.02 9.03 9.04 9.05 9.06 9.07 9.08 9.09 9.10 9.11 Watson WJ, Demarchi G (August 1987). "Vaginal discharge: an approach to diagnosis and management". Can Fam Physician. 33: 1847–52. PMC 2218224. PMID 21263805.
- ↑ 10.0 10.1 10.2 10.3 10.4 "Trichomoniasis - 2015 STD Treatment Guidelines".
- ↑ 11.0 11.1 11.2 11.3 11.4 11.5 11.6 11.7 "Bacterial Vaginosis - 2015 STD Treatment Guidelines".
- ↑ Sim, M; Logan, S; Goh, LH (2020). "Vaginal discharge: evaluation and management in primary care". Singapore Medical Journal: 297–301. doi:10.11622/smedj.2020088. ISSN 0037-5675.
Template:Skin and subcutaneous tissue symptoms and signs Template:Nervous and musculoskeletal system symptoms and signs Template:Urinary system symptoms and signs Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:Speech and voice symptoms and signs Template:General symptoms and signs